*以來,澳大利亞Panbio公司在臨床實驗室應用的創(chuàng)新性的檢測產(chǎn)品開發(fā)方面一直保持的良好記錄、是目前世界上zui*的診斷試劑生產(chǎn)商。 Panbio一直在登革熱(Dengue fever)、羅斯河熱(Ross river fever)的診斷試劑產(chǎn)品方面保持著*的市場地位。公司的西尼羅河腦炎(West Nile encephalopalitis)診斷試劑在獲得美國FDA注冊。 Panbio登革產(chǎn)品擁有zui廣的產(chǎn)品系列,有著zui廣的應用。
Panbio empowers people to take control of their health by actively integrating diagnostics and health management solutions to provide timely, actionable information in a range of environments from hospital to home. We provide in vitro diagnostics in the fields of cardiovascular, infectious diseases, women's health, prenatal care, drugs of abuse and oncology. We support healthcare workers and patients by developing simple diagnostic equipment to ensure better quality in both inpatient and outpatient care.
Through the strategic acquisition of a number of companies, we have steadily grown and have expanded our product and service offering. We are a market leader engaged in health care management programs and services and offer comprehensive support for health care professionals and patients across the globe.
We are a global leader in the field of rapid diagnostic tests which are designed to improve the quality of patient care. Specific product lines include tests for the rapid and early diagnosis of myocardial infarction, influenza, acute kidney damage, HIV infection, and for the exclusion of acute risk of premature labour and delivery. We also support the patients' ability to self-manage a number of common health issues, for example by offering an easy-to-use device to monitor blood coagulation. A device patients may use in the home.
By supplying products that are accurate, effective, consistent and reliable for use in both the home and clinical environments, Alere is enabling doctors and patients to better connect with each other and provide the information necessary to make better healthcare decisions.
China's general agent: GuangZhou Jianlun biology Technology Co.,Ltd +86-/+86- Service@jianlun.com